title: [The strategy for chemotherapy-induced myelosuppression].
abstract: Myelosuppression is one of the most serious adverse effects induced by chemotherapy targeting solid tumors and hematological malignancies, and results in neutropenia, anemia and thrombocytopenia. In particular, prompt and appropriate treatments are required for febrile neutropenia, because that disease may be fatal.
authors.affiliation: Division of Hematology, NTT Medical Center, Tokyo, Japan.
authors.forename: Akira
authors.initials: A
authors.lastname: Hangaishi
mesh_terms: D000740:Anemia / Q000139:chemically induced / Q000628:therapy; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D042381:Granulocyte Precursor Cells / Q000166:cytology / Q000187:drug effects*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D009503:Neutropenia / Q000139:chemically induced / Q000628:therapy; D013921:Thrombocytopenia / Q000139:chemically induced / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents